NCT01776658View on ClinicalTrials.gov

Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2015

Conditions
Ocular PainDry Eye Syndrome
Interventions
DRUG

SYL1001

Ocular topical administration of SYL1001 for 10 consecutive days

DRUG

Placebo

Ocular topical administration of placebo for 10 consecutive days

Trial Locations (3)

28040

Fundación Jiménez Díaz, Madrid

Hospital Universitario Clínico San Carlos, Madrid

33012

Instituto Oftalmológico Fernández-Vega, Oviedo

All Listed Sponsors
lead

Sylentis, S.A.

INDUSTRY

NCT01776658 - Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain | Biotech Hunter | Biotech Hunter